R. Garcia-Ruiz, A. L. Gutierrez-Valdez, V. Anaya-Martinez, C. Torres-Esquivel, Jesus Espinosa-Villanueva, L. Reynoso-Erazo, M. Moreno-Rivera, P. Aley-Medina, J. Sanchez-Betancourt, E. Montiel-Flores, C. Sanchez Vazquez del Mercado, M. R. Avila-Costa, Antidyskinetic effect of L-DOPA/rimonabant or L-DOPA/capsazepine oral co-administration in a rat model of Parkinson disease. Behavioral and cytological evidences

Site Search:

CLINICAL AND EXPERIMENTAL MEDICAL SCIENCES

ISSN 1314-7528 (print) ISSN 1314-7676 (online)

R. Garcia-Ruiz, A. L. Gutierrez-Valdez, V. Anaya-Martinez, C. Torres-Esquivel, Jesus Espinosa-Villanueva, L. Reynoso-Erazo,
M. Moreno-Rivera, P. Aley-Medina, J. Sanchez-Betancourt, E. Montiel-Flores, C. Sanchez Vazquez del Mercado, M. R. Avila-Costa
Antidyskinetic effect of L-DOPA/rimonabant or L-DOPA/capsazepine oral co-administration in a rat model of Parkinson disease.
Behavioral and cytological evidences
Clinical and Experimental Medical Sciences, Vol. 1, 2013, no. 5-8, 263-290
http://dx.doi.org/10.12988/cems.2013.13022
Copyright © 2013 R. Garcia-Ruiz, A. L. Gutierrez-Valdez, V. Anaya-Martinez, C. Torres-Esquivel, Jesus Espinosa-Villanueva, L. Reynoso-Erazo, M. Moreno-Rivera, P. Aley-Medina, J. Sanchez-Betancourt, E. Montiel-Flores, C. Sanchez Vazquez del Mercado and M. R. Avila-Costa. This article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cited by (1):
Silvia Cerri, Giovanna Levandis, Giulia Ambrosi, Elena Montepeloso, Gian Filippo Antoninetti, Rafael Franco, Jose Luis Lanciego, Younis Baqi, Christa E. Muller, Annalisa Pinna, Fabio Blandini, Marie Therese Armentero, Neuroprotective potential of adenosine A_2A and cannabinoid CB_1 receptor antagonists in an animal model of Parkinson disease, Journal of Neuropathology and Experimental Neurology, 73 (2014), no. 5, 414-424 [CrossRef]

Journals | Books | Author guidelines